- Sermorelin offer
- $199/month; one-month injection supply
- Purchase scope
- Confirm all care charges and renewal conditions
- Evidence
- Public-page review; no firsthand treatment or service testing
A separate sermorelin offer within a large catalog
Shed's sermorelin page presents an injection at $199 per month with a one-month supply. That product-specific statement is the useful starting point for a provider comparison. The site also sells other treatment categories, whose introductory prices, benefit claims and guarantees should not be carried over into the sermorelin offer without explicit support.
The service describes an online assessment, clinician review and pharmacy fulfillment when a prescription is appropriate. This profile evaluates the public offer and care pathway. We have not completed intake, obtained medication or independently measured support quality, shipping performance or outcomes among patients using the prescribed preparation.
A monthly figure needs a complete care invoice
The one-month supply wording provides a defined commercial period, unlike an unspecified vial price. It still does not establish the full cost of every aspect of care. Confirm whether the selected quote covers consultation, necessary supplies, delivery and continuing clinical access, and identify any required testing or other services billed separately.
Also ask whether the amount changes with a different prescription or future renewal. A product card is not a complete subscription contract. The final order should show the initial payment, next billing date and any additional membership or service charge if one applies, rather than relying on terms advertised for another part of Shed's catalog.
Prescribing and fulfillment have different responsibilities
The treating clinician should explain the intended use, eligibility assessment and monitoring plan. The dispensing pharmacy should identify the preparation, its concentration and quantity, and the storage and beyond-use conditions. Those details cannot be inferred from the site's general healthy-aging language or from a monthly supply description alone.
Find out which support channel handles a delayed package, a product-quality concern or a medical question after delivery. Access to an account or portal does not itself establish a guaranteed clinical response time. A practical service comparison should make those responsibilities clear before the convenience of online ordering is treated as the whole care experience.
Compounding and evidence remain part of the review
Shed discloses that compounded medications are not FDA-approved. The presence of a clinician in the pathway does not change that product status or prove broad claims about recovery, sleep or body composition. Relevant evidence should concern the intended use, population and preparation, with its limitations explained during the medical assessment.
For readers comparing providers, the documented strengths are a separate sermorelin listing and an explicit monthly supply description. The pharmacy specification, full invoice and ongoing-care terms still need confirmation. Our assessment keeps those purchasing facts distinct from unverified health outcomes and does not use customer stories or unrelated medication promotions as evidence that this compounded treatment will work for a particular person.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.